MedPath

内蒙古黄河制药厂

Ownership
-
Established
1989-03-31
Employees
-
Market Cap
-
Website
www.nmghhzy.cn

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

90

NMPA:90

Drug Approvals

Tabellae Acidi Acetyls Alicylici Compositae

Product Name
复方乙酰水杨酸片
Approval Number
国药准字H15020996
Approval Date
Apr 26, 2020
NMPA

Nitrendipine Tablets

Product Name
尼群地平片
Approval Number
国药准字H15020396
Approval Date
Apr 26, 2020
NMPA

板蓝根颗粒

Approval Number
国药准字Z15021516
Approval Date
Apr 26, 2020
NMPA

Naproxen Tablets

Product Name
萘普生片
Approval Number
国药准字H15021000
Approval Date
Apr 26, 2020
NMPA

Cefalexin Capsules

Product Name
头孢氨苄胶囊
Approval Number
国药准字H15020398
Approval Date
Apr 26, 2020
NMPA

Chlormphenicol Tablets

Product Name
氯霉素片
Approval Number
国药准字H15020362
Approval Date
Apr 26, 2020
NMPA

Piracetam Capsules

Product Name
吡拉西坦胶囊
Approval Number
国药准字H15021266
Approval Date
Apr 26, 2020
NMPA

TABELLAE FURAZOLLDONI

Product Name
呋喃唑酮片
Approval Number
国药准字H15020554
Approval Date
Apr 26, 2020
NMPA

Nifedipine Tablets

Product Name
硝苯地平片
Approval Number
国药准字H15020371
Approval Date
Apr 26, 2020
NMPA

Metamizole Sodium Tablets

Product Name
安乃近片
Approval Number
国药准字H15020358
Approval Date
Apr 26, 2020
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 9
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.